Billionaire Bill Gates' Foundation Sold Its Microsoft Stake and Has 43% of Its $33 Billion Portfolio Invested in 2 Other Stocks

The Gates Foundation’s $33 billion public equity portfolio remains concentrated in two core holdings: Berkshire Hathaway at about 25% and WM at about 18%, while Microsoft exposure is being reduced as Bill Gates continues donating shares. Microsoft trades at 25x forward earnings despite strong AI, cloud, and software growth, while Berkshire trades near a 1.4x price-to-book and WM near 27x earnings, both framed as fair-to-attractive valuations. The article is primarily an investment commentary rather than a catalyst-driven news event.

Analysis

The portfolio shift is less about a change in view on Microsoft than about balance-sheet engineering: when a concentrated donor base already has enormous direct exposure to a single name, reducing duplication lowers single-name risk without changing the economic exposure to the broader equity market. That creates a subtle overhang for MSFT only if the foundation becomes a persistent source of supply, but the more important signal is that long-duration capital is preferring businesses where cash flows are easier to underwrite through a full cycle.

The bigger second-order implication is for BRK.B and WM: both benefit from a scarcity premium inside institutional “quality/value” baskets. If Gates-style allocators continue favoring cash-generative franchises with low operational complexity, these names can keep attracting marginal flows even when valuation looks full, because their appeal is less about near-term upside and more about drawdown resistance. That said, both are now priced to perfection relative to their growth rates, so the setup is good for owning them on dips, not chasing strength.

Contrarian takeaway: the market may be underestimating how neutral this is for Microsoft fundamentals. At a forward multiple near the low-20s/mid-20s, the stock is no longer being valued purely as an AI call option; it is increasingly a high-quality cash compounder with buyback support. The cleaner opportunity is relative value: long MSFT against lower-quality software or megacap tech where AI enthusiasm has outrun monetization, and long BRK.B/WM only on pullbacks because their forward returns are likely to come from compounding, not multiple expansion.

Key Decisions for Investors

• Long MSFT vs. a basket of slower-monetizing AI beneficiaries on a 3-6 month horizon; target a modest 1.5-2.0x upside to downside if AI capex keeps translating into Azure/SaaS revenue while lower-quality peers re-rate lower.
• Buy BRK.B on any 3-5% pullback, with a 6-12 month hold; risk/reward favors capital preservation and low-beta compounding, but upside is capped if buybacks remain subdued and book-value valuation normalizes.
• Accumulate WM only on weakness, not at current premium multiples; use a 12-month horizon and treat it as a defensive compounder, but expect limited multiple expansion from here.
• Pair trade: long MSFT / short a basket of high-multiple software names with weaker free-cash-flow conversion; this isolates quality and valuation discipline if AI spending rotates from narrative to monetization.
• Avoid chasing the foundation-style value trade after a strong run; the best entry is typically after 5-10% sector-wide risk-off moves, when these names can be bought without paying peak scarcity premium.